4//SEC Filing
Fitzgerald Meghan 4
Accession 0001140361-24-040986
CIK 0001635088other
Filed
Sep 11, 8:00 PM ET
Accepted
Sep 12, 9:00 PM ET
Size
7.2 KB
Accession
0001140361-24-040986
Insider Transaction Report
Form 4
Fitzgerald Meghan
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-09-10+27,894→ 27,894 totalExercise: $12.19Exp: 2034-09-09→ Common Shares (27,894 underlying) - Award
Common Shares
2024-09-10+16,406→ 30,270 total
Footnotes (2)
- [F1]Reflects an annual award of restricted stock units with respect to Common Shares ("RSUs") granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy. The award of RSUs is scheduled to vest 100% on September 10, 2025, subject generally to the reporting person's continuous service through such date.
- [F2]Reflects an annual award of stock options to purchase Common Shares granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy. The award of stock options is scheduled to vest and become exercisable 100% on September 10, 2025, subject generally to the reporting person's continuous service through such date.
Documents
Issuer
Roivant Sciences Ltd.
CIK 0001635088
Entity typeother
Related Parties
1- filerCIK 0001349297
Filing Metadata
- Form type
- 4
- Filed
- Sep 11, 8:00 PM ET
- Accepted
- Sep 12, 9:00 PM ET
- Size
- 7.2 KB